Search
Citations & References (17)
Gibco™
StemPro™-34 SFM (1X)
StemPro-SFM 34は、骨髄、新生児の臍帯血、末梢血から単離したHSC細胞や前駆細胞など、培養におけるヒト造血細胞の成長をサポートするために特別調製された無血清培地です。StemPro-34 SFMは、さまざまなアプリケーションに利用できる柔軟な細胞培養培地です。詳細を見る
| 製品番号（カタログ番号） | 数量 |
|---|---|
| 10639011 | 500 mL |
製品番号（カタログ番号） 10639011
価格（JPY）お問い合わせください ›
45,900
Each
数量:
500 mL
StemPro-SFM 34は、骨髄、新生児の臍帯血、末梢血から単離したHSC細胞や前駆細胞など、培養におけるヒト造血細胞の成長をサポートするために特別調製された無血清培地です。StemPro-34 SFMは、さまざまなアプリケーションに利用できる柔軟な細胞培養培地です。
ヒトex vivo組織および細胞培養処理用。注意：医療機器として使用する場合は、米国連邦法により、本機器の販売は医師自身が行うか、医師の指示にしたがって行うよう制限されています。
仕様
細胞タイプHematopoietic Stem Cell, Hematopoietic Cell, Bone Marrow
エンドトキシンレベル≤ 10 EU/mL
製品ラインStemPro
製品タイプStem Cell Serum Free Media (SFM)
数量500 mL
種Human
分類Serum-free
Culture TypeStationary Suspension Culture
形状Liquid
Serum LevelSerum-free
添加剤ありPhenol Red
添加剤なしNo Glutamine
Unit SizeEach
組成および保存条件
• 500 ml StemPro™-34 Serum Free Medium (store at 2°C to 8°C in the dark)
• 13 ml StemPro™-34 Nutrient Supplement (store at -5°C to -20°C in the dark)
Store the complete medium at 2°C to 8°C in the dark.
• 13 ml StemPro™-34 Nutrient Supplement (store at -5°C to -20°C in the dark)
Store the complete medium at 2°C to 8°C in the dark.
引用および参考文献 (17)
引用および参考文献
Abstract
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells.
Journal:Nature communications
PubMed ID:31628330
In the human hematopoietic system, rare self-renewing multipotent long-term hematopoietic stem cells (LT-HSCs) are responsible for the lifelong production of mature blood cells and are the rational target for clinical regenerative therapies. However, the heterogeneity in the hematopoietic stem cell compartment and variable outcomes of CRISPR/Cas9 editing make functional interrogation
Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs.
Journal:Respiratory research
PubMed ID:23522153
BACKGROUND: We investigated the capacity of expanded cord blood-derived CD34+ hematopoietic progenitor cells to undergo respiratory epithelial differentiation ex vivo, and to engraft and attenuate alveolar disruption in injured newborn murine lungs in vivo. METHODS: Respiratory epithelial differentiation was studied in CD34+ cells expanded in the presence of growth factors
Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
Journal:PloS one
PubMed ID:21364915
BACKGROUND: Differentiation of pluripotent stem cells in vitro provides a powerful means to investigate early developmental fates, including hematopoiesis. In particular, the use of a fully defined medium (FDM) would avoid biases induced by unidentified factors contained in serum, and would also allow key molecular mediators involved in such a
Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.
Journal:Blood
PubMed ID:17148580
The onset of hematopoiesis in the mouse embryo and in the embryonic stem (ES) cell differentiation model is defined by the emergence of the hemangioblast, a progenitor with both hematopoietic and vascular potential. While there is evidence for the existence of a hemangioblast in the mouse, it is unclear if
Differentiation of Human-Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics.
Journal:Current protocols in stem cell biology
PubMed ID:30537374
Macrophages play important roles in many diseases. We describe a protocol and the associated resources for the differentiation of human induced pluripotent stem cell-derived macrophages (IPSDM) and their applications in understanding human macrophage physiology and relevant diseases. The protocol uses an embryoid bodyâbased approach with a combination of serum-free condition